Dear Colleagues, Modelling and simulation group at UCB is looking for an experienced pharmacometrician to join our team. The position can be based in Slough, UK or Braine, Belgium.
Preferred Background: PhD in PK-PD or Pharmacometrics with Drug Development Experience. Interested colleagues please send your CV directly to me at pavan.vaj...@ucb.com or can apply via the link below https://careers.ucb.com/job/Slough-Advanced-Modelling-&-Simulation-Expert-Pharmacometrician-Berk/545361101/ Kind regards Pavan Position: Advanced Modelling & Simulation Expert – Pharmacometrician At UCB everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” We do that by connecting with patients and their families around the world living with the physical and social burdens of severe disease of the immune system and the central nervous system. Those connections offer new perspectives, drive innovation, and offer the hope of a new generation of therapies that will help to transform lives. Help us transform patients’ lives. At UCB, we put our heart, soul and skills into making a difference for people living with severe disease. Working together to push the boundaries, we blend the best of our talents to unlock innovation. Will you join us in our pioneering adventure? Role Overview In this key role he/she will serve as the Advanced Modelling and Simulation/Pharmacometric Expert. Working within a matrix team supporting early (pre-POC) and late phase (post-POC) projects to deliver and apply quantitative solutions to drive the delivery of the translational and clinical development plan. Working mainly outside the classical clinical/project team frame-work, dealing directly with key individuals (Quantitative Clinical Pharmacologist, Exploratory Statistician, Biomarkers and Therapeutic Experts) to scope the key question/concept, plan a solution, and lead its execution and delivery, providing an answer. In particular, he/she will provide specialized pharmacometric expertise to multiple projects, and will work within a dedicated team along with an external network of experts to support the delivery of analyses, enhance project impact, develop and apply new methodologies and solutions, whilst remaining at the cutting edge in terms of expertise. Main Accountabilities •Accountable for scoping and delivering the pharmacometric strategy for assigned projects •Developing disease-based PK-PD models and meta-analyses to support translation, risk assessment through various decision points (FIH, POC to PH3) in the key (Immunology, Neuroscience, Bone) UCB’s therapeutic areas •Providing analyses to support the recommendations for clinical doses and dosing algorithms to the clinical and Development teams and in regulatory documentation. •Accountable for providing advanced mechanistic modelling support for evaluation of key assets, prior to candidate selection •Provide guidance to the quantitative pharmacologist on optimal PK and PK-PD sampling for implementation in the various stages of development, and subsequently perform the population PK and PK-PD analyses (safety and efficacy) on a continuous and live basis as the project progresses. •Evaluate the potential use of different technologies and approaches to support project progression e.g. empirical approach, systems pharmacology, sparse methodology •Accountable and responsible for key technical reports (e.g. population PK, PK-PD, trial simulations as well as sections of regulatory documents). •Initiating and managing collaborations with external experts. Technical Capabilities Functional scientific skills, including; •Physiological and biochemical understanding •Mathematical/statistical skills •Therapeutic Expertise •Experience in pharmacokinetics/pharmacodynamic modelling •Non Linear Mixed Effects Modelling •Knowledge of drug development and the application of modelling in the regulatory and decision making setting •Proficiency in performing data analysis and interpretation with several pieces of software such as; oNonMem and add-ons (PsN, XPose, Pirana, Navigator….) oR oPhoenix oBerkeley Madonna oMatLab Essential Requirements Educated to Pharm D or PhD (or equivalent) with demonstrated experience (with examples of impact) in the conduct and application of M&S, preferably in the pharmaceutical industry, consultancy group or academic setting. This experience can be validated via publication. •Effective oral and written communication skills both within the expert domain and effective with non-experts •Able to communicate complex modelling concepts and results effectively to other functions and project teams •Strong leadership skills •Efficient time management and organization skills •Ability to work in a matrix team •Ability to produce and present quality scientific papers at external meetings and for publication Pavan Vajjah, MPharm, PhD Head of Advanced Modelling and Simulation Development Sciences UCB Celltech, Slough, UK Email: pavan.vaj...@ucb.com Mob: +44-7785-556322 ________________________________ UCB Celltech is the UK branch of UCB Pharma S.A., a company registered in Belgium with registered offices at Allée de la Recherche 60, 1070 Brussels, Belgium, KBO/BCE nr. 0403.096.168, RPR/RPM Brussels. UCB Celltech’s UK branch registration number is BR009137 and its UK representative office is at 208 Bath Road, Slough, Berkshire SL1 3WE. (Ref: #*CUK0308) [Ref-CUK0308] ________________________________ Legal Notice: This electronic mail and its attachments are intended solely for the person(s) to whom they are addressed and contain information which is confidential or otherwise protected from disclosure, except for the purpose for which they are intended. Dissemination, distribution, or reproduction by anyone other than the intended recipients is prohibited and may be illegal. If you are not an intended recipient, please immediately inform the sender and return the electronic mail and its attachments and destroy any copies which may be in your possession. UCB screens electronic mails for viruses but does not warrant that this electronic mail is free of any viruses. UCB accepts no liability for any damage caused by any virus transmitted by this electronic mail. (Ref: #*UG1107) [Ref-UG1107] ________________________________
